Legato Capital Management LLC - GLENMARK PHARMACEUTICALS LTD ownership

Back to all holdings Add to watchlist

GLENMARK PHARMACEUTICALS LTD's ticker is and the CUSIP is 006698755. A total of 1 filers reported holding GLENMARK PHARMACEUTICALS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
Quarter-by-quarter ownership
Legato Capital Management LLC ownership history of GLENMARK PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2017$2,176,000
+30.5%
233,480
+28.2%
0.31%
+26.2%
Q3 2017$1,668,000–182,077–0.25%–
 Download
Other shareholders
GLENMARK PHARMACEUTICALS LTD shareholders Q3 2017
NameSharesValueWeighting ↓
Legato Capital Management LLC 182,077$1,668,0000.25%
View complete list of GLENMARK PHARMACEUTICALS LTD shareholders